By: Allyson Chiu
For the past 10 years, Mark Albers has studied how existing medications could be repurposed to treat Alzheimer's, a disease that's expected to double in prevalence by 2060 and has no cure.


Allyson Chiu is a Climate Solutions Reporter at The Washington Post. She focuses on health and wellness within the context of climate change, exploring the intersection of environmental issues and public health. Allyson's work has been featured in numerous publications, including The Philadelphia Tribune, Yahoo News, and The New York Times.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)


Not enough data
Allyson Chiu's coverage shows a focus on environment and scientific topics, with an emphasis on practical advice backed by data. Her articles often cite data and include "how-to" guides, making her receptive to pitches that provide actionable tips supported by credible information.
Given the focus on environmental themes like sustainability and wildlife, experts in these areas who can offer practical guidance or insights based on scientific research are likely to appeal to Allyson. Pitches providing unique perspectives or new data-driven approaches related to winter survival, food science, sustainability practices, energy efficiency, and wildlife would align well with her coverage style.
Since Allyson has a national geographic focus within the United States (Washington D.C.), she may also be interested in receiving pitches that have relevance specifically for this region concerning environmental policies or initiatives.
This information evolves through artificial intelligence and human feedback. Improve this profile .